Nebenwirkungen · Nplate
Nplate 125 micrograms powder for solution for injection Nplate 250 micrograms powder for solution for injection Nplate 500 micrograms powder for solution for injection · Abschnitt 4.8 · PDF-Seite 12
HOS-119971 · Präparat HOS-095065
Across the entire adult ITP clinical programme an inverse relationship between bleeding events and platelet counts was observed. All clinically significant (≥ grade 3) bleeding events occurred at platelet counts < 30 x 109/L. All bleeding events ≥ grade 2 occurred at platelet counts < 50 x 109/L. No statistically significant differences in the overall incidence of bleeding events were observed between Nplate and placebo treated patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-15T10:00:00Z · SHA-256 21915ee595896e145725c8b0c0727c67621ba960c30c78fb042e65240af0bac5 · Passage a4031d64db7bae9a27f48665cf4632f3f7673a687069e3e12ab60ffb16f2307f · Zeichen 14709–15150 im Abschnitt